A new study by researchers at The Pirbright Institute shows that avian influenza viruses can combine two techniques to evade vaccine immunity, aiding their spread in the field. Understanding the dynamics between these methods could allow researchers to develop better vaccines that prevent flu viruses circumventing the immune response.
After four weeks of intensive training, Dr Yaoyao Zhang departed CN Bio Innovations, a Cambridge-based bioengineering company, ready to incorporate new technology and skills into her own research at The Pirbright Institute.
An enzyme called trypsin boosts the growth of infectious bronchitis virus (IBV) strains in lab cell cultures, scientists at The Pirbright Institute have shown. This finding could enable researchers to study strains of the poultry virus that were previously inaccessible and potentially provide alternative vaccine production methods, which currently rely on eggs, therefore reducing the numbers of birds needed for research and vaccine production.
® The Pirbright Institute 2024 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.
